CUE Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: CUE's innovations in immunotherapy may trigger breakthroughs. High implied volatility hints at potential price spikes; clinical results could catalyze further interest despite historical downtrends.




Bearish Case: CUE's persistent underperformance and flat term structure imply difficulty overcoming operational challenges. Skepticism over trial timelines and financial viability increase risk without significant catalysts.




Potential Outcomes:
  1. Positive trial results trigger a spike (25%).
  2. Continued decline amid operational setbacks (50%).
  3. Stagnation in current trading range (15%).
  4. Unforeseen negative catalysts deepen losses (10%).



May 14, 2025


Cue Biopharma Forecast

CUE        Cue Biopharma











Correlated Assets

Assets that tend to move strongly with CUE



LAC Forecast + Options Trading Strategies   LAC  Lithium Americas (0.74)


LIT Forecast + Options Trading Strategies   LIT  Global X Lithium & Battery Tech (0.72)


TDOC Forecast + Options Trading Strategies   TDOC  Teladoc Health (0.71)


MNSO Forecast + Options Trading Strategies   MNSO  MINISO Group Holding Ltd (0.71)


QYLD Forecast + Options Trading Strategies   QYLD  Global X NASDAQ 100 Covered Call (0.68)



Uncorrelated Assets

Assets with little price relationship to CUE



HASI Forecast + Options Trading Strategies   HASI  Hannon Armstrong Sustainable Infrastructure (0.0)


BABA Forecast + Options Trading Strategies   BABA  Alibaba (0.0)


BZH Forecast + Options Trading Strategies   BZH  Beazer Homes USA (0.01)


UNM Forecast + Options Trading Strategies   UNM  Unum (0.01)


USAU Forecast + Options Trading Strategies   USAU  U.S. Gold (0.01)



Anticorrelated Assets

Assets that tend to move strongly against CUE



O Forecast + Options Trading Strategies   O  Realty Income (-0.48)


POST Forecast + Options Trading Strategies   POST  Post (-0.54)


KO Forecast + Options Trading Strategies   KO  Coca-Cola (-0.58)


YCL Forecast + Options Trading Strategies   YCL  ProShares Ultra Yen (-0.65)


BIV Forecast + Options Trading Strategies   BIV  Vanguard Group, Inc. - Vanguard Intermediate-Term Bond (-0.68)









Become a more profitable investor with AI optimized trading strategies






×

Chat with CUE


 Ask any question about CUE!